(Total Views: 622)
Posted On: 11/05/2021 11:23:43 PM
Post# of 154945
Another fine post! Enjoy this one!
Aaron
Amarex MSA:
Section 2.1: Amarex will perform the services with due care and diligence...
Section 2.2: Amarex will perform the services in an efficient and timely manner to achieve the timetables and milestones set forth in each project work order.
Section 9.1:. Amarex warrants that it shall provide the services as set forth in section 2.1
Section 9.2: Cytodyn's remedy for a breach of the warranty... .....(
return of the fees paid In connection with applicable services.
Section 9.3: In no event shall Amarex be responsible or liable for an aggregate damage total in excess of the value paid by Cytodyn under the applicable work order giving rise to damages: PROVIDED HOWEVER THAT THIS LIMITATION DOES NOT APPLY IN THE EVENT OF AMAREX GROSS NEGLIGENCE OR WILLFUL MISCONDUCT...
From Nader Pourhassen written statement to the court, Cytodyn vs. Amarex:
"The FDA's refusal to file... And it's letter regarding Amarex's failure to file IND annual reports on Cytodyn's behalf show that the FDA already has concerns... Because of Amarex's failures as CRO."
..... okay if you read this far, guess what direction you think this is heading?"
Aaron
Amarex MSA:
Section 2.1: Amarex will perform the services with due care and diligence...
Section 2.2: Amarex will perform the services in an efficient and timely manner to achieve the timetables and milestones set forth in each project work order.
Section 9.1:. Amarex warrants that it shall provide the services as set forth in section 2.1
Section 9.2: Cytodyn's remedy for a breach of the warranty... .....(
return of the fees paid In connection with applicable services. Section 9.3: In no event shall Amarex be responsible or liable for an aggregate damage total in excess of the value paid by Cytodyn under the applicable work order giving rise to damages: PROVIDED HOWEVER THAT THIS LIMITATION DOES NOT APPLY IN THE EVENT OF AMAREX GROSS NEGLIGENCE OR WILLFUL MISCONDUCT...
From Nader Pourhassen written statement to the court, Cytodyn vs. Amarex:
"The FDA's refusal to file... And it's letter regarding Amarex's failure to file IND annual reports on Cytodyn's behalf show that the FDA already has concerns... Because of Amarex's failures as CRO."
..... okay if you read this far, guess what direction you think this is heading?"
(17)
(0)
